Comparative safety of abatacept in rheumatoid arthritis with COPD: A real-world population-based observational study

Study identification

• EU PAS number:
  EUPAS25405
• Study ID:
  25561
• Official title and acronym:
  Comparative safety of abatacept in rheumatoid arthritis with COPD: A real-world population-based observational study
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  No information provided.
• Study status:
  Ongoing

Research institutions and networks

Institutions

Centre d'Épidémiologie Clinique de Montreal

Study timelines

Date when funding contract was signed

Actual:19/10/2016

Study start date

Actual:01/01/2007

Date of final study report

Planned:31/10/2018

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Bristol-Myers Squibb

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable